002728 特一药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.4044.5551.08614.83213.375
总资产报酬率 ROA (%)1.1113.4660.83410.0107.728
投入资产回报率 ROIC (%)1.1723.6290.86910.5358.131

边际利润分析
销售毛利率 (%)60.98654.62543.92056.14949.036
营业利润率 (%)16.9708.7773.50727.48022.169
息税前利润/营业总收入 (%)17.0709.0933.10227.90624.557
净利润/营业总收入 (%)12.2768.8342.98023.72320.100

收益指标分析
经营活动净收益/利润总额(%)89.27689.215117.108101.83996.315
价值变动净收益/利润总额(%)3.9800.96716.9410.1230.173
营业外收支净额/利润总额(%)-1.3631.379-9.364-0.095-0.114

偿债能力分析
流动比率 (X)2.0101.8881.5952.3731.018
速动比率 (X)1.4311.3651.1521.7890.830
资产负债率 (%)20.65321.19726.48819.97744.880
带息债务/全部投入资本 (%)14.94814.77922.26314.62540.373
股东权益/带息债务 (%)557.767565.587341.446573.437144.273
股东权益/负债合计 (%)384.200371.756277.530400.570122.817
利息保障倍数 (X)51.97447.188-29.78661.72510.179

营运能力分析
应收账款周转天数 (天)27.26133.63251.44032.26234.608
存货周转天数 (天)271.789215.397250.233184.643160.762